← Open Payments lookup

NPI 1730101668: Open Payments

NPI 1730101668. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$213 in 10 payments from 4 companies in 2025. Trend: 2023 $1,632 · 2024 $1,908 · 2025 $213

Food & beverage: $213
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$89
Lundbeck LLC2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Teva Pharmaceuticals USA, Inc.2$32

Products named: INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, UZEDY.